Price
1,243.7
+0.34%52W Range
Market Cap
₹14,159.31 Cr
Traded: ₹56.44 Cr (0.40%) 0.0x
Free Float: ₹1,408.85 Cr (4.01% of FF traded)
Volume · 60D trend
4.55 L 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| ROE | -- | +6.0% | +5.0% | -- | -- | Decelerating |
| Sales | -- | +24.0% | +14.0% | -- | +52.0% | Stable |
| Profit | -- | +19.0% | -2.0% | -- | +42.0% | Stable |
| Return | -- | +10.0% | +9.0% | +5.0% | -- | Decelerating |
Quarterly Results
Dec 2022
Sep 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023PDF ↗ | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 655 | 636 | 512 | 731 | 486 | 500 | 390 | 294 | 254 | 401 | 296 | 392 | 386 | 480 | 392 | 393 |
| Expenses | 493 | 498 | 385 | 596 | 362 | 356 | 266 | 214 | 201 | 308 | 216 | 285 | 285 | 363 | 281 | 282 |
| Operating Profit | 162 | 137 | 127 | 136 | 124 | 144 | 124 | 80 | 53 | 93 | 79 | 107 | 101 | 117 | 111 | 111 |
| OPM % | 25.0% | 22.0% | 25.0% | 19.0% | 26.0% | 29.0% | 32.0% | 27.0% | 21.0% | 23.0% | 27.0% | 27.0% | 26.0% | 24.0% | 28.0% | 28.0% |
| Other Income | 13 | 3 | 2 | 8 | 5 | 6 | -4 | 2 | 6 | 12 | 2 | 3 | 12 | 24 | -3 | -10 |
| Interest | 49 | 42 | 35 | 36 | 36 | 31 | 32 | 27 | 22 | 26 | 25 | 20 | 18 | 20 | 14 | 16 |
| Depreciation | 56 | 43 | 34 | 32 | 31 | 31 | 29 | 22 | 21 | 21 | 20 | 20 | 19 | 19 | 18 | 18 |
| Profit Before Tax | 70 | 56 | 60 | 76 | 63 | 88 | 59 | 34 | 16 | 58 | 36 | 71 | 77 | 103 | 75 | 67 |
| Tax % | 27.0% | 0.0% | -1.0% | 24.0% | 23.0% | 29.0% | 9.0% | 10.0% | 25.0% | 30.0% | 28.0% | 31.0% | 32.0% | 29.0% | 28.0% | 29.0% |
| Net Profit | 51 | 56 | 61 | 57 | 48 | 63 | 54 | 31 | 12 | 40 | 26 | 49 | 52 | 73 | 54 | 48 |
| Exceptional Items | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| EPS (Rs) | 3.4 | 3.8 | 4.3 | 3.9 | 3.1 | 4.0 | 2.6 | 1.5 | 0.4 | 2.8 | 1.7 | 3.8 | 3.6 | 5.3 | 4.0 | 4.2 |
| Sales Growth (YoY) | 34.8% | 27.2% | 31.3% | 148.6% | 91.3% | 24.7% | 31.8% | -25.0% | -34.2% | -16.5% | -24.5% | -0.3% | -- | -- | -- | -- |
| Sales Growth (QoQ) | 3.0% | 24.2% | -30.0% | 50.4% | -2.8% | 28.2% | 32.6% | 15.8% | -36.7% | 35.5% | -24.5% | 1.6% | -19.6% | 22.4% | -0.3% | -- |
| OP Growth (YoY) | 30.6% | -4.9% | 2.4% | 70.0% | 134.0% | 54.8% | 57.0% | -25.2% | -47.5% | -20.5% | -28.8% | -3.6% | -- | -- | -- | -- |
| OP Growth (QoQ) | 18.2% | 7.9% | -6.6% | 9.7% | -13.9% | 16.1% | 55.0% | 50.9% | -43.0% | 17.7% | -26.2% | 5.9% | -13.7% | 5.4% | 0.0% | -- |
| Profit Growth (YoY) | -- | -4.0% | 74.0% | 166.0% | 768.0% | 44.0% | 53.0% | -59.0% | -90.0% | -45.0% | -57.0% | -2.0% | -3.0% | 23.0% | 13.0% | 15.0% |
| EPS Growth (YoY) | 9.3% | -7.4% | 68.4% | 156.6% | 761.1% | 43.6% | 52.4% | -59.8% | -90.0% | -46.5% | -58.0% | -8.9% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -9.6% | -13.0% | 10.5% | 25.8% | -23.5% | 58.2% | 68.4% | 322.2% | -87.2% | 67.9% | -55.6% | 5.3% | -31.9% | 31.8% | -3.6% | -- |
| OP Margin | 24.7% | 21.5% | 24.8% | 18.6% | 25.5% | 28.8% | 31.8% | 27.2% | 20.9% | 23.2% | 26.7% | 27.3% | 26.2% | 24.4% | 28.3% | 28.2% |
| Net Margin | 7.8% | 8.8% | 11.9% | 7.8% | 9.9% | 12.6% | 13.8% | 10.5% | 4.7% | 10.0% | 8.8% | 12.5% | 13.5% | 15.2% | 13.8% | 12.2% |
| Material Cost % | -- | 52.0% | 53.0% | 65.0% | 50.0% | 47.0% | 40.0% | 37.0% | 40.0% | 47.0% | 34.0% | 41.0% | 42.0% | 49.0% | 43.0% | 41.0% |
| Employee Cost % | -- | 5.0% | 4.0% | 2.0% | 4.0% | 4.0% | 5.0% | 6.0% | 7.0% | 4.0% | 7.0% | 5.0% | 5.0% | 3.0% | 5.0% | 5.0% |
| P/S | 5.59 | 5.81 | 6.78 | 6.70 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 81.02 | 80.20 | 86.47 | 91.06 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 4.25 | 4.12 | 4.73 | 4.41 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Submission of transcript of earnings call on the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 14, 2026 for Anand Sureshbhai Desai
Submission of newspaper advertisement clippings pertaining to the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2026
Submission of Audio Recording of Earnings Call pertaining to the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026.
Investor Presentation regarding Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026.
Press Release regarding Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026.
The Board of Directors at its meeting held on August 14, 2026 has considered and approved the unaudited financial results (standalone & consolidated) of the company for the quarter ended ....
The Board of Directors at its meeting held on August 14, 2026 has considered and approved the appointment of Mr. Ravi Desai as Chief Operating Officer of the Company with effect from August 14, 2026.
The Board of Directors at its meeting held today i.e. August 14, 2026, has inter-alia, considered and approved the Unaudited Financial Results (Standalone & Consolidated) for the quarter ....
Nomination and Remuneration Committee of the Board at its meeting held on August 13, 2026, has approved the allotment of 1531 equity shares under ESOP Scheme.
Intimation of the Earnings Call on the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2026, scheduled to be held on Friday, August 14, 2026, at ....
Anupam Rasayan India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve the Unaudited Financial ....
Submission of newspaper advertisement clippings pertaining to the Pre-Offer Advertisement and Corrigendum to the Detailed Public Statement
Submission of Letter of Offer regarding the open offer for acquisition of fully paid-up equity shares of Bliss GVS Pharma Limited from the Public Shareholders, by the Company together with PAC
Submission of copy of newspaper advertisement clippings pertaining to the Addendum to the Public Announcement, Detailed Public Statement and Draft Letter of Offer.
Acquisition of shares
Press Release Intimation titled "Anupam Rasayan signs Letter of Intent with BASQUEVOLT, S.A. for the potential long-term supply of a specialty chemical product worth ?300 Mn.
Confirmation Certificate of Non-Applicability of Reg. 74(5) of SEBI (DP) Regulations.
The Trading Window shall remain closed from Wednesday, July 01, 2026 till the end of 48 hours after the declaration of the Unaudited Financial Results (Standalone and Consolidated) of the ....
Intimation of Press Release titled "Anupam Rasayan India Limited becomes the first company in the world to commercialise ETFA (Ethyl trifluoroacetate) using flow chemistry"
Pursuant to Regulation 30 of the SEBI Listing Regulations, please find attached Draft Letter of Offer filed by the Manager to the Offer with SEBI yesterday, relating to the mandatory open ....
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 01, 2026 for Anand Sureshbhai Desai
Copy of newspaper advertisement published pertaining to the Detailed Public Statement for the Open Offer to public shareholders of Bliss GVS Pharma Limited
Submission of Transcript of Earnings Call on the Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended 31.03.2026.
Submission of Annual Secretarial Compliance Report for the financial year ended March 31, 2026.
Allotment of non convertible debentures
Submission of Audio Recording of the Earnings Call on the Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended March 31, 2026.
Newspaper Publication regarding Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended March 31, 2026.
Audited Financial Results for the quarter and financial year ended March 31, 2026.
The Board of Directors of the Company has approved and recommended the payment of final dividend on the equity shares of the Company for the FY 2025-26.
Disclosure under Regulation 30 of SEBI LODR pursuant to outcome of Board Meeting.
Intimation of resignation of Mr. Vishal Thakkar, Deputy CFO and KMP of the Company.
The Board of Directors of the Company at its meeting held on May 23, 2026, has approved the re-appointment of Internal Auditor and Cost Auditor of the Company.
Share Purchase Agreement proposed to be executed between identified sellers, the target and the Company.
Intimation of Press Release titled "Anupam Rasayan India Limited enters into a definitive agreement to acquire 43.3-48.2% equity stake + open offer to the public shareholders of Bliss GVS ....
Investor Presentation in respect of Audited Financial Results for the quarter and financial year ended March 31, 2026.
Investor Presentation regarding Bliss GVS Pharma Limited Acquisition.
Intimation of Press Release regarding the Audited Financial Results for the quarter and financial year ended March 31, 2026.
Outcome of Board Meeting held on May 23, 2026.
Anupam Rasayan India Limited has informed the exchange about the Earnings Call on the Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended March ....
Anupam Rasayan India Limited has informed the Exchange that the meeting of the Board of Directors of the Company is scheduled on May 23, 2026, to consider and recommend the final dividend ....
Anupam Rasayan India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2026 ,inter alia, to consider and approve the Audited Financial ....
Submission of the minutes of the ordinary/special resolutions passed by way of Postal Ballot by the members of the Company.
Submission of Scrutinizer''s Report and E-voting Results of Postal Ballot.
Confirmation Certificate of Non-Applicablity of Reg. 74(5) of SEBI (DP) Regulations, 2018.
Submission of Newspaper Advertisement Clippings pertaining to Postal Ballot Notice and Remote E-voting intimation to the members of the Company.
Intimation of Postal Ballot Notice dated April 06, 2026.
Anupam Rasayan India Limited has informed the exchange about the Outcome of Board Meeting held today i.e. on April 06, 2026.
The trading window shall remain closed from Wednesday, April 01, 2026 till the end of 48 hours after the announcement/declaration of the Audited Financial Results (Standalone and Consolidated) ....
Intimation of Credit Rating by Crisil Ratings Limited.
Credit Ratings
6Concalls
23Feb 2026
28 Feb 2026Dec 2025
31 Dec 2025Oct 2025
31 Oct 2025Aug 2025
31 Aug 2025May 2025
31 May 2025Feb 2025
28 Feb 2025Nov 2024
30 Nov 2024Aug 2024
31 Aug 2024Aug 2024
31 Aug 2024May 2024
31 May 2024Feb 2024
29 Feb 2024Nov 2023
30 Nov 2023Aug 2023
31 Aug 2023May 2023
31 May 2023Jan 2023
31 Jan 2023Nov 2022
30 Nov 2022Jul 2022
31 Jul 2022May 2022
31 May 2022Feb 2022
28 Feb 2022Nov 2021
30 Nov 2021Nov 2021
30 Nov 2021Aug 2021
31 Aug 2021Jun 2021
30 Jun 2021Held by ETFs
9 ETFs hold ANURAS · sorted by weight
Held by Mutual Funds
16 schemes hold ANURAS · sorted by weight